Literature DB >> 7888355

The association between lichen sclerosus and antigens of the HLA system.

P Marren1, J Yell, F M Charnock, M Bunce, K Welsh, F Wojnarowska.   

Abstract

Although frequently linked clinically with autoimmune disease, no immunogenetic basis for lichen sclerosus has ever been established. In this study, we examined in detail the HLA antigens of 84 patients with histologically proven disease, compared with 357 controls. Patients with lichen sclerosus did not have the expected HLA A1, B8, DR3, DQ2 autoimmune profile. Instead, DQ7 was present in 39 of 78 (50%) of patients compared with 89 (25%) controls (P < 0.001). In addition, 61 of 78 patients (78%) had either DQ7, DQ8 or DQ9 antigens, or a combination of these, compared with 142 (40%) controls (P < 0.01). Raised levels of DQ7 correspond to a glutamic acid residue at position 45 of the DQB1 locus. Proline amino acids at position 55 of this DQB1 locus could explain the raised levels of DQ7, 8 and 9, and exert a secondary effect. There is preliminary evidence that the immunogenetic profile of patients with this disease may affect disease expression with regard to site and extent of involvement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7888355     DOI: 10.1111/j.1365-2133.1995.tb05013.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  19 in total

Review 1.  Topical interventions for genital lichen sclerosus.

Authors:  Ching-Chi Chi; Gudula Kirtschig; Maha Baldo; Fabia Brackenbury; Fiona Lewis; Fenella Wojnarowska
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Extragenital lichen sclerosus with aetiological link to Borrelia.

Authors:  Biju Vasudevan; Amitabh Sagar; Ashish Bahal; A P Mohanty
Journal:  Med J Armed Forces India       Date:  2011-10-22

Review 3.  [Lichen sclerosus : Symptoms, diagnosis, therapeutic procedures].

Authors:  G Kirtschig
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

Review 4.  The Immunogenetics of Morphea and Lichen Sclerosus.

Authors:  Pooya Khan Mohammad Beigi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Transcriptome Profiling and Network Analysis Provide Insights Into the Pathogenesis of Vulvar Lichen Sclerosus.

Authors:  Lingyan Wang; Qingqing Lv; Jiayi Guo; Jianwei Wang; Jing Pan
Journal:  Front Genet       Date:  2022-06-17       Impact factor: 4.772

6.  Anogenital lichen sclerosus in women.

Authors:  R H Thomas; C M Ridley; D H McGibbon; M M Black
Journal:  J R Soc Med       Date:  1996-12       Impact factor: 18.000

Review 7.  Vulvar lichen sclerosus in the elderly: pathophysiology and treatment update.

Authors:  Natalie A Saunders; Hope K Haefner
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 8.  Vulvar pruritus-Causes, Diagnosis and Therapeutic Approach.

Authors:  Linn Woelber; Katharina Prieske; Werner Mendling; Barbara Schmalfeldt; Hans-Jürgen Tietz; Anna Jaeger
Journal:  Dtsch Arztebl Int       Date:  2020-02-21       Impact factor: 5.594

Review 9.  Diagnosis and treatment of lichen sclerosus: an update.

Authors:  Susanna K Fistarol; Peter H Itin
Journal:  Am J Clin Dermatol       Date:  2013-02       Impact factor: 7.403

10.  Genital vulvar lichen sclerosus in monozygotic twin women: a case report and review of the literature.

Authors:  Georgeta Doulaveri; Kalliopi Armira; Anargyros Kouris; Dimitrios Karypidis; Irene Potouridou
Journal:  Case Rep Dermatol       Date:  2013-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.